Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
affirming, Anderson, ASCO, ASM, atezolizumab, aumolertinib, ballot, bevacizumab, Carter, CDPA, Colorado, combat, compensatory, constitutionality, CPA, CPDA, CPRA, CSPC, dismissed, effort, entry, excessive, gouging, governor, heard, InnoCare, instructed, intentionally, MCL, MD, Orion, payable, Percy, preapproval, presidential, Restoring, scrutiny, setup, spread, substitution, timeline, tracing, University, unnecessary, vested, Virginia, waiver
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view